Pages that link to "Q39255218"
Jump to navigation
Jump to search
The following pages link to Strategies for monitoring and combating resistance to combination kinase inhibitors for cancer therapy (Q39255218):
Displaying 7 items.
- Acquired resistance to PI3K/mTOR inhibition is associated with mitochondrial DNA mutation and glycolysis (Q47143132) (← links)
- Cis-oriented solvent-front EGFR G796S mutation in tissue and ctDNA in a patient progressing on osimertinib: a case report and review of the literature. (Q49643911) (← links)
- JAK/Stat5-mediated subtype-specific lymphocyte antigen 6 complex, locus G6D (LY6G6D) expression drives mismatch repair proficient colorectal cancer (Q61445424) (← links)
- A System-wide Approach to Monitor Responses to Synergistic BRAF and EGFR Inhibition in Colorectal Cancer Cells (Q63804827) (← links)
- Stochastic modelling of tyrosine kinase inhibitor rotation therapy in chronic myeloid leukaemia. (Q64956787) (← links)
- Genomics-Guided Immunotherapy for Precision Medicine in Cancer (Q91956657) (← links)
- Resistance to MET/VEGFR2 Inhibition by Cabozantinib Is Mediated by YAP/TBX5-Dependent Induction of FGFR1 in Castration-Resistant Prostate Cancer (Q92815489) (← links)